載入...
Diclofenac and the Risk of Rhabdomyolysis: Analysis of Publications and the WHO Global Pharmacovigilance Database
BACKGROUND: Diclofenac, a nonsteroidal anti-inflammatory drug, is not a documented cause of rhabdomyolysis in the Summaries of Product Characteristics held by major regulators. There are, however, eight published single case reports that associate rhabdomyolysis with diclofenac. OBJECTIVE: Triggered...
Na minha lista:
| 發表在: | Drugs Real World Outcomes |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer International Publishing
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8324666/ https://ncbi.nlm.nih.gov/pubmed/33786776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40801-021-00240-z |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|